SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026171
Filing Date
2018-05-08
Accepted
2018-05-08 16:47:18
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv492231_10q.htm 10-Q 314710
2 EXHIBIT 4.1 tv492231_ex4-1.htm EX-4.1 33244
3 EXHIBIT 31.1 tv492231_ex31-1.htm EX-31.1 11761
4 EXHIBIT 32.1 tv492231_ex32-1.htm EX-32.1 4681
5 GRAPHIC tv492231_img1.jpg GRAPHIC 86442
  Complete submission text file 0001144204-18-026171.txt   3311268

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT syn-20180331.xml EX-101.INS 698087
7 XBRL TAXONOMY EXTENSION SCHEMA syn-20180331.xsd EX-101.SCH 35120
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20180331_cal.xml EX-101.CAL 32665
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20180331_def.xml EX-101.DEF 211666
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20180331_lab.xml EX-101.LAB 261530
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20180331_pre.xml EX-101.PRE 242054
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 18815372
SIC: 2834 Pharmaceutical Preparations